These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31431359)

  • 1. Correlation of indoleamine-2,3-dioxigenase 1 inhibitory activity of 4,6-disubstituted indazole derivatives and their heme binding affinity.
    Tsujino H; Uno T; Yamashita T; Katsuda M; Takada K; Saiki T; Maeda S; Takagi A; Masuda S; Kawano Y; Meguro K; Akai S
    Bioorg Med Chem Lett; 2019 Oct; 29(19):126607. PubMed ID: 31431359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and preliminary structure-activity relationship of 1H-indazoles with promising indoleamine-2,3-dioxygenase 1 (IDO1) inhibition properties.
    Qian S; He T; Wang W; He Y; Zhang M; Yang L; Li G; Wang Z
    Bioorg Med Chem; 2016 Dec; 24(23):6194-6205. PubMed ID: 27769672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4,6-Substituted-1H-Indazoles as potent IDO1/TDO dual inhibitors.
    Yang L; Chen Y; He J; Njoya EM; Chen J; Liu S; Xie C; Huang W; Wang F; Wang Z; Li Y; Qian S
    Bioorg Med Chem; 2019 Mar; 27(6):1087-1098. PubMed ID: 30773421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Apo-Form Selective Inhibition of Indoleamine 2,3-Dioxygenase*.
    Ortiz-Meoz RF; Wang L; Matico R; Rutkowska-Klute A; De la Rosa M; Bedard S; Midgett R; Strohmer K; Thomson D; Zhang C; Mebrahtu M; Guss J; Totoritis R; Consler T; Campobasso N; Taylor D; Lewis T; Weaver K; Muelbaier M; Seal J; Dunham R; Kazmierski W; Favre D; Bergamini G; Shewchuk L; Rendina A; Zhang G
    Chembiochem; 2021 Feb; 22(3):516-522. PubMed ID: 32974990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and preliminary structure-activity relationships of 1-Indanone derivatives as novel indoleamine-2,3-dioxygenase 1 (IDO1) inhibitors.
    Gao D; Li Y
    Bioorg Med Chem; 2017 Jul; 25(14):3780-3791. PubMed ID: 28526475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of 5-(pyridin-3-yl)-1H-indole-4,7-diones as indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
    Kong KM; Zhang JW; Liu BZ; Meng GR; Zhang Q
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126901. PubMed ID: 31882299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of 2,5-dimethylfuran-3-carboxylic acid derivatives as potential IDO1 inhibitors.
    Yang X; Cai S; Liu X; Chen P; Zhou J; Zhang H
    Bioorg Med Chem; 2019 Apr; 27(8):1605-1618. PubMed ID: 30858027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form.
    Nelp MT; Kates PA; Hunt JT; Newitt JA; Balog A; Maley D; Zhu X; Abell L; Allentoff A; Borzilleri R; Lewis HA; Lin Z; Seitz SP; Yan C; Groves JT
    Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3249-3254. PubMed ID: 29531094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taking advantage of the interaction between the sulfoxide and heme cofactor to develop indoleamine 2, 3-dioxygenase 1 inhibitors.
    Wang Y; Jia S; Chen Y; Liao X; Jie R; Jiang L; Wang T; Wen H; Gan W; Cui H
    Bioorg Chem; 2024 Jul; 148():107426. PubMed ID: 38733750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of novel tryptanthrin derivatives as dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase.
    Li Y; Zhang S; Wang R; Cui M; Liu W; Yang Q; Kuang C
    Bioorg Med Chem Lett; 2020 Jun; 30(11):127159. PubMed ID: 32247733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azole-Based Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Röhrig UF; Majjigapu SR; Reynaud A; Pojer F; Dilek N; Reichenbach P; Ascencao K; Irving M; Coukos G; Vogel P; Michielin O; Zoete V
    J Med Chem; 2021 Feb; 64(4):2205-2227. PubMed ID: 33557523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel IDO1 inhibitors via structure-based virtual screening and biological assays.
    Ge H; Mao L; Zhao J; Wang Y; Shi D; Yang X; Wang X; Liu H; Yao X
    J Comput Aided Mol Des; 2021 May; 35(5):679-694. PubMed ID: 33905074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Molecular Modeling Studies of N'-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
    Lee DH; Lee JY; Jeong J; Kim M; Lee KW; Jang E; Ahn S; Lee CH; Hwang JY
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29120388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis and Biological Evaluation of Phenyl Urea Derivatives as IDO1 Inhibitors.
    Zhou C; Lai F; Sheng L; Chen X; Li Y; Feng Z
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32210078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design, synthesis and biological evaluation of ubiquinone derivatives as IDO1 inhibitors.
    Ding Y; Tang F; Xue X; Luo J; Hussain M; Huang Y; Wang Z; Jiang H; Tu Z; Zhang J
    Bioorg Chem; 2019 Aug; 89():102870. PubMed ID: 31103493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrobenzofurazan derivatives of N'-hydroxyamidines as potent inhibitors of indoleamine-2,3-dioxygenase 1.
    Paul S; Roy A; Deka SJ; Panda S; Trivedi V; Manna D
    Eur J Med Chem; 2016 Oct; 121():364-375. PubMed ID: 27267006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis and Biological Evaluation of Novel 1,2,5-Oxadiazol-3- Carboximidamide Derivatives as Indoleamine 2, 3-Dioxygenase 1 (IDO1) Inhibitors.
    Xia Z; Nan Y; Liu C; Lin G; Gu K; Chen C; Zhao W; Ju D; Dong X
    Anticancer Agents Med Chem; 2020; 20(13):1592-1603. PubMed ID: 32496990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of immunosuppressive indoleamine 2,3-dioxygenase by targeting the heme and apo-form.
    Pradhan N; Akhtar N; Nath B; Peña-García J; Gupta A; Pérez-Sánchez H; Kumar S; Manna D
    Chem Commun (Camb); 2021 Jan; 57(3):395-398. PubMed ID: 33326535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4,5-Disubstituted 1,2,3-triazoles: Effective Inhibition of Indoleamine 2,3-Dioxygenase 1 Enzyme Regulates T cell Activity and Mitigates Tumor Growth.
    Panda S; Pradhan N; Chatterjee S; Morla S; Saha A; Roy A; Kumar S; Bhattacharyya A; Manna D
    Sci Rep; 2019 Dec; 9(1):18455. PubMed ID: 31804586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and evaluation of inhibitors to the immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (IDO1): Probing the active site-inhibitor interactions.
    Tomek P; Palmer BD; Flanagan JU; Sun C; Raven EL; Ching LM
    Eur J Med Chem; 2017 Jan; 126():983-996. PubMed ID: 28011425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.